Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1936-0541
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study ; volume:16 ; number:5 ; day:25 ; month:8 ; year:2022 ; pages:1170-1178 ; date:10.2022
Hepatology international ; 16, Heft 5 (25.8.2022), 1170-1178, 10.2022

Urheber
Patwala, Kurvi
Prince, David Stephen
Celermajer, Yael
Alam, Waafiqa
Paul, Eldho
Strasser, Simone Irene
McCaughan, Geoffrey William
Gow, Paul
Sood, Siddharth
Murphy, Elise
Roberts, Stuart
Freeman, Elliot
Stratton, Elizabeth
Davison, Scott Anthony
Levy, Miriam Tania
Clark-Dickson, McCawley
Nguyen, Vi
Bell, Sally
Nicoll, Amanda
Bloom, Ashley
Lee, Alice Unah
Ryan, Marno
Howell, Jessica
Valaydon, Zina
Mack, Alexandra
Liu, Ken
Dev, Anouk
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s12072-022-10398-5
URN
urn:nbn:de:101:1-2022123109273920087186
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:23 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Patwala, Kurvi
  • Prince, David Stephen
  • Celermajer, Yael
  • Alam, Waafiqa
  • Paul, Eldho
  • Strasser, Simone Irene
  • McCaughan, Geoffrey William
  • Gow, Paul
  • Sood, Siddharth
  • Murphy, Elise
  • Roberts, Stuart
  • Freeman, Elliot
  • Stratton, Elizabeth
  • Davison, Scott Anthony
  • Levy, Miriam Tania
  • Clark-Dickson, McCawley
  • Nguyen, Vi
  • Bell, Sally
  • Nicoll, Amanda
  • Bloom, Ashley
  • Lee, Alice Unah
  • Ryan, Marno
  • Howell, Jessica
  • Valaydon, Zina
  • Mack, Alexandra
  • Liu, Ken
  • Dev, Anouk
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study

Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study

Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis

Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis

Sorafenib versus lenvatinib-based sequential systemic therapy for advanced hepatocellular carcinoma: a real-world analysis

Sorafenib versus lenvatinib-based sequential systemic therapy for advanced hepatocellular carcinoma: a real-world analysis

Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study

Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study

Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: a comparative analysis in a European real-world cohort

Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: a comparative analysis in a European real-world cohort

Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in China

Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in China

Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea

Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea

Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma Showing Pathological Complete Response to Lenvatinib Monotherapy

Hepatocellular Carcinoma Showing Pathological Complete Response to Lenvatinib Monotherapy

Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients

Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients

Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications

Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications

Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma

Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma

Verbundene Objekte